Pharma M&A Case Study: Gilead Sciences’s acquisition of Kite Pharma
Posted on03 Sep 2017
Comments0
Gilead Sciences is in process of acquiring Kite Pharma, one of the most advanced players in the CAR-T therapy market. In this... Read More
Gilead gets Indian patent for Hepatitis C drug Solvadi
Brand Name: Sovaldi Molecule: Sofosbuvir Innovator Company: Gilead Sciences In direct contradiction to its earlier order, the Controller General of Patents, Designs... Read More
Blockbuster “Sofosbuvir” Hepatitis C drug now under price control in India
National Pharmaceutical Pricing Authority (NPPA) has brought under price control revolutionary drug ‘Sofosbuvir’ prescribed for patients with Hepatitis C. Sofosbuvir cannot be... Read More
Top 20 Global Pharma Brands by Sales in 2014
Top 20 Pharma Brands Globally By Sales Rank 2014 Sales (US$ Mn) 2013 Sales (US$ Mn) Growth Rate GLOBAL MARKET 9,36,511... Read More
ZydusCadila to launch Gilead’s Sovaldi in India
Posted on20 Mar 2015
TagsSofosbuvir, Sovaldi, Zydus biosimilar, Zydus Gliead deal, Zydus Heptiza, ZydusCadila to launch Gilead's Sovaldi in India
Comments0
The two companies have entered into a generic, non-exclusive licensing agreement to manufacture Sofobuvir and an investigational single tablet regime of Ledipasvir/... Read More
Gilead’s Sovaldi Vs. AbbVie’s Viekira Pak
Competitor: Gilead’s Sovaldi Pricing: Gilead’s Sovaldi AbbVie’s Viekira Pak 84000 USD 83319 USD Gilead’s Sovaldi treatment stole headlines last year with its $84,000... Read More